UnitedHealth Group (UNH) reported third-quarter 2026 revenue of $112.7 billion, compared with $113.2 billion a year earlier, and earnings from operations of $6.6 billion, versus $4.3 billion. Diluted earnings per share were $4.56 and adjusted diluted earnings per share were $4.69, compared with $2.59 and $2.92, respectively. Cash flows from operations were $5.1 billion, and the medical care ratio was 88.4%, versus 89.9% a year earlier; the quarter included $610 million of net favorable prior-period reserve development related to 2026 dates of service.
The company raised its full-year 2026 outlook to at least $19.50 per share in diluted earnings and at least $20.50 per share in adjusted earnings. UnitedHealthcare served 48.3 million people and reported $86.3 billion in revenue; Optum reported $66.9 billion in revenue. Optum Health revenue declined 10% year over year as fewer value-based care patients were served in markets where it lacked sufficient value-based care presence to sustain its clinicians. Year to date, the company repurchased $5.0 billion of common stock and paid $6.2 billion in dividends.
UnitedHealth Group (UNH) director John H. Noseworthy acquired 240 deferred stock units on October 1, 2026, as regular quarterly compensation for director service. His reported direct holdings after the transaction were 7,902 shares.
UnitedHealth Group Inc. director Valerie Montgomery Rice, MD, acquired 257 deferred stock units on October 1, 2026, as regular quarterly compensation for Board service. The units were immediately vested but must be retained until she completes service on the Board. Her reported direct holdings after the award were 8,180 shares.
UnitedHealth Group director Frederick William McNabb III received a grant of 291 deferred stock units on October 1, 2026, as regular quarterly compensation for Board service. The units were immediately vested, but must be retained until he completes his service on the Board. The reported price per share was $0.00.
UnitedHealth Group Inc. (UNH) director Scott Gottlieb acquired 257 deferred stock units on October 1, 2026, as regular quarterly compensation. His directly held position after the transaction was 921 shares.
UnitedHealth Group Inc. (UNH) director Gil Kristen acquired 240 shares of common stock on October 1, 2026, as deferred stock units. The units were immediately vested but must be retained until completion of Board service. After the award, Kristen directly held 2,867 shares; a separate indirect holding through a trust was reported as 3,800 shares.
UnitedHealth Group Inc. director Paul R. Garcia received 155 deferred stock units and 103 shares of common stock as regular quarterly compensation on October 1, 2026. The deferred stock units are immediately vested but must be retained until he completes Board service. Reported indirect holdings included 2,146 shares in Revocable Trust, 45 in Trust 2 and 55 in Trust 3.
UnitedHealth Group Inc. director Timothy Patrick Flynn acquired 262 deferred stock units on October 1, 2026, as regular quarterly compensation for Board service. The units were immediately vested but must be retained until he completes service on the Board. His reported direct common-stock holdings following the transaction were 11,205 shares; a separate 6,033 shares were held indirectly by trust.
UnitedHealth Group Inc. director Charles D. Baker acquired 257 deferred stock units on October 1, 2026, as regular quarterly compensation for Board service. The units vested immediately but must be retained until he completes service on the Board. His reported position following the transaction was 2,668 shares.
UnitedHealth Group Inc. director Frederick William McNabb III acquired 57 shares on September 22, 2026, as dividend equivalents paid on vested deferred stock units. The dividend equivalents were immediately vested and are subject to the same terms as the underlying deferred stock units. After the transaction, he directly held 15,519 shares. No Rule 10b5-1 plan is reported.